Skip to content
10-Q

Quarterly Report

SPRING PHARMACEUTICAL GROUP, INC.

0001096906-19-000070

← back to feed
Filed
Feb 14, 2019 12:00 AM ET
Period of report

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q3 2019 · Feb 14, 2019 29.84M sh
Capex Q3 2019 · Dec 31, 2018 $91.58K
Capex Q3 2019 · Dec 31, 2017 $2.13M
Cash And Equivalents Q3 2019 · Dec 31, 2018 $35.96M
Cash And Equivalents Q3 2019 · Mar 31, 2018 $25.35M
Cash And Equivalents Q3 2019 · Dec 31, 2017 $18.77M
Cash And Equivalents Q3 2019 · Mar 31, 2017 $10.31M
Stockholders Equity Q3 2019 · Dec 31, 2018 $108.95M
Stockholders Equity Q3 2019 · Mar 31, 2018 $105.11M
Current Liabilities Q3 2019 · Dec 31, 2018 $2.18M
Current Liabilities Q3 2019 · Mar 31, 2018 $1.98M
Current Assets Q3 2019 · Dec 31, 2018 $41.78M
Current Assets Q3 2019 · Mar 31, 2018 $30.07M
Total Assets Q3 2019 · Dec 31, 2018 $114.3M
Total Assets Q3 2019 · Mar 31, 2018 $110.14M
Sga Expense Q3 2019 · Dec 31, 2018 $1.31M
Sga Expense Q3 2019 · Dec 31, 2018 $3.5M
Sga Expense Q3 2019 · Dec 31, 2017 $1.45M
Sga Expense Q3 2019 · Dec 31, 2017 $3.22M
Rd Expense Q3 2019 · Dec 31, 2018 $297.09K
Rd Expense Q3 2019 · Dec 31, 2018 $688.25K
Rd Expense Q3 2019 · Dec 31, 2017 $280.23K
Rd Expense Q3 2019 · Dec 31, 2017 $406.64K
Net Income Q3 2019 · Dec 31, 2018 $4.48M
Net Income Q3 2019 · Dec 31, 2018 $13.31M
Net Income Q3 2019 · Dec 31, 2017 $2.86M
Net Income Q3 2019 · Dec 31, 2017 $9.1M
Operating Income Q3 2019 · Dec 31, 2018 $5.93M
Operating Income Q3 2019 · Dec 31, 2018 $17.63M
Operating Income Q3 2019 · Dec 31, 2017 $3.78M
Operating Income Q3 2019 · Dec 31, 2017 $11.47M
Gross Profit Q3 2019 · Dec 31, 2018 $8.82M
Gross Profit Q3 2019 · Dec 31, 2018 $25.81M
Gross Profit Q3 2019 · Dec 31, 2017 $6.79M
Gross Profit Q3 2019 · Dec 31, 2017 $18.69M
Cost Of Revenue Q3 2019 · Dec 31, 2018 $10.67M
Cost Of Revenue Q3 2019 · Dec 31, 2018 $33.26M
Cost Of Revenue Q3 2019 · Dec 31, 2017 $10.42M
Cost Of Revenue Q3 2019 · Dec 31, 2017 $29.52M
Revenue Q3 2019 · Dec 31, 2018 $19.49M
Revenue Q3 2019 · Dec 31, 2018 $59.07M
Revenue Q3 2019 · Dec 31, 2017 $17.21M
Revenue Q3 2019 · Dec 31, 2017 $48.21M